Profusa, Inc. Common Stock

NASDAQ PFSA
$0.19 0.0000 -0.41%
์˜ค๋Š˜ ์ฃผ๊ฐ€
๋ฏธ๊ตญ
์ ‘๊ทผ ๊ถŒํ•œ์„ ์–ป๋‹ค
Finrange ์ฃผ์‹ ๋“ฑ๊ธ‰์—
์ด ์š”๊ธˆ์ œ๋ฅผ ์ด์šฉํ•˜๋ฉด ์ œํ•œ ์—†์ด ์„œ๋น„์Šค๋ฅผ ์ด์šฉํ•  ์ˆ˜ ์žˆ์œผ๋ฉฐ ๋ชจ๋“  ์ •๋ณด๋ฅผ ์ด์šฉํ•  ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.
์–ป๋‹ค 7์ผ ๋ฌด๋ฃŒ

๋“ฑ๊ธ‰ ํ•€ ๋ฒ”์œ„

์ƒ‰์ธ: %
Market cap ์‹œ๊ฐ€์ด์•ก โ€“ ํšŒ์‚ฌ์˜ ๋ชจ๋“  ์ฃผ์‹ ์ฃผ์‹์˜ ์ด ๊ฐ€์น˜๋ฅผ ๋‚˜ํƒ€๋ƒ…๋‹ˆ๋‹ค. ์ด๋Š” ํŠน์ • ์ฃผ์‹์˜ ๊ฐ€๊ฒฉ์— ๋ฐœํ–‰ ์ฃผ์‹์ˆ˜๋ฅผ ๊ณฑํ•˜์—ฌ ๊ณ„์‚ฐ๋ฉ๋‹ˆ๋‹ค.
-
EV ๊ธฐ์—… ๊ฐ€์น˜๋Š” ํšŒ์‚ฌ์˜ ์ด ๊ฐ€์น˜๋ฅผ ์ธก์ •ํ•œ ๊ฒƒ์œผ๋กœ, ์ข…์ข… ์ฃผ์‹ ์‹œ๊ฐ€์ด์•ก์— ๋Œ€ํ•œ ๋ณด๋‹ค ํฌ๊ด„์ ์ธ ๋Œ€์•ˆ์œผ๋กœ ์‚ฌ์šฉ๋ฉ๋‹ˆ๋‹ค. ๊ธฐ์—… ๊ฐ€์น˜์—๋Š” ํšŒ์‚ฌ์˜ ์‹œ๊ฐ€์ด์•ก๋ฟ๋งŒ ์•„๋‹ˆ๋ผ ๋‹จ๊ธฐ ๋ฐ ์žฅ๊ธฐ ๋ถ€์ฑ„์™€ ํšŒ์‚ฌ ๋Œ€์ฐจ๋Œ€์กฐํ‘œ์˜ ํ˜„๊ธˆ๋„ ํฌํ•จ๋ฉ๋‹ˆ๋‹ค.
-
Beta ๋ฒ ํƒ€๋Š” ๊ฐ€์žฅ ๋„๋ฆฌ ์‚ฌ์šฉ๋˜๋Š” ์œ„ํ—˜ ์ง€ํ‘œ ์ค‘ ํ•˜๋‚˜์ด๋ฉฐ ํ†ต๊ณ„์  ์ฒ™๋„์ž…๋‹ˆ๋‹ค. ๋ถ„์„๊ฐ€๋“ค์€ ์ฃผ์‹์˜ ์œ„ํ—˜ ํ”„๋กœํ•„์„ ๊ฒฐ์ •ํ•ด์•ผ ํ•  ๋•Œ ์ด ์ฒ™๋„๋ฅผ ์ž์ฃผ ์‚ฌ์šฉํ•ฉ๋‹ˆ๋‹ค.
-
Shares ๋ฐœํ–‰ ์ฃผ์‹์ˆ˜๋Š” ๊ธฐ๊ด€ ํˆฌ์ž์ž๊ฐ€ ๋ณด์œ ํ•œ ์ฃผ์‹ ๋ธ”๋ก๊ณผ ํšŒ์‚ฌ ๋‚ด๋ถ€์ž๊ฐ€ ์†Œ์œ ํ•œ ์ œํ•œ๋œ ์ฃผ์‹์„ ํฌํ•จํ•˜์—ฌ ํ˜„์žฌ ๋ชจ๋“  ์ฃผ์ฃผ๊ฐ€ ๋ณด์œ ํ•˜๊ณ  ์žˆ๋Š” ํšŒ์‚ฌ์˜ ์ฃผ์‹์„ ์˜๋ฏธํ•ฉ๋‹ˆ๋‹ค.
32.79M
YTD ์—ฐ์ดˆ(YTD)๋Š” ๊ธˆ๋…„ ๋˜๋Š” ํšŒ๊ณ„์—ฐ๋„์˜ ์ฒซ๋‚ ๋ถ€ํ„ฐ ํ˜„์žฌ ๋‚ ์งœ๊นŒ์ง€์˜ ๊ธฐ๊ฐ„์„ ๋‚˜ํƒ€๋ƒ…๋‹ˆ๋‹ค. ๊ทธ ์•ฝ์–ด๋Š” ์ข…์ข… ํˆฌ์ž ์ˆ˜์ต ๋ฐ ๊ฐ€๊ฒฉ ๋ณ€ํ™”์™€ ๊ฐ™์€ ๊ฐœ๋…์„ ์ˆ˜์ •ํ•ฉ๋‹ˆ๋‹ค.
-

๋‹ค๊ฐ€์˜ค๋Š” ์ด๋ฒคํŠธ Profusa, Inc. Common Stock

๋ชจ๋“  ์ด๋ฒคํŠธ
์˜ˆ์ •๋œ ํ–ฅํ›„ ์ด๋ฒคํŠธ๊ฐ€ ์—†์Šต๋‹ˆ๋‹ค.

์ฃผ์‹ ์ฐจํŠธ Profusa, Inc. Common Stock

์ฃผ์‹๋ถ„์„ Profusa, Inc. Common Stock

์ง€์‹œ์ž ํšŒ์‚ฌ ์‚ฐ์—…
P/E (LTM) ์ง€๋‚œ 12๊ฐœ์›” ๋™์•ˆ ํšŒ์‚ฌ์— ๋Œ€ํ•œ ํˆฌ์ž์ž์˜ ํˆฌ์ž๊ฐ€ ๋ช‡ ๋…„ ๋™์•ˆ ์ด์ต์œผ๋กœ ๋ณด์ƒ๋˜๋Š”์ง€ ๋ณด์—ฌ์ค๋‹ˆ๋‹ค.
- -2.55
P/BV (LTM) ํ˜„์žฌ ์žฅ๋ถ€๊ฐ€์น˜์— ๋Œ€ํ•œ ์ฃผ์‹์˜ ์‹œ์žฅ ๊ฐ€๊ฒฉ ๋น„์œจ์„ ํ‘œ์‹œํ•ฉ๋‹ˆ๋‹ค.
- 1.31
EV/EBITDA (LTM) ์ง€๋‚œ 12๊ฐœ์›” ๋™์•ˆ ํšŒ์‚ฌ ๊ฐ€์น˜์™€ ์„ธ์ „ EBITDA์˜ ๋น„์œจ์„ ๋‚˜ํƒ€๋ƒ…๋‹ˆ๋‹ค.
- -2.52
Net Debt/EBITDA (LTM) ํšŒ์‚ฌ์˜ ๋ถ€์ฑ„ ๋น„์œจ์€ ํšŒ์‚ฌ๊ฐ€ ๋ถ€์ฑ„๋ฅผ ์ƒํ™˜ํ•˜๊ธฐ ์œ„ํ•ด ์ง€๋‚œ 12๊ฐœ์›” ๋™์•ˆ ํ˜„๊ธˆ ํ๋ฆ„์„ ์–ผ๋งˆ๋‚˜ ์˜ค๋žซ๋™์•ˆ ์šด์˜ํ•ด์•ผ ํ•˜๋Š”์ง€๋ฅผ ๋‚˜ํƒ€๋ƒ…๋‹ˆ๋‹ค.
- 0.35
ROE (LTM) ํšŒ์‚ฌ์˜ ์ฃผ์‹ ์ž๋ณธ ์‚ฌ์šฉ ํšจ์œจ์„ฑ์„ ๋ณด์—ฌ์ค๋‹ˆ๋‹ค. ์ฆ‰, ROE๋Š” ์ง€๋‚œ 12๊ฐœ์›” ๋™์•ˆ ํˆฌ์žํ•œ ์ž๋ณธ์— ๋Œ€ํ•œ ํšŒ์‚ฌ์˜ ์ˆœ์ด์ต์ด ์–ผ๋งˆ์ธ์ง€๋ฅผ ๋‚˜ํƒ€๋ƒ…๋‹ˆ๋‹ค.
- -40.79

์—ฐ๊ฐ„ ๊ฐ€๊ฒฉ ๋ณ€๋™ Profusa, Inc. Common Stock

0.18$ 2.50$
์ตœ์†Œ ๋งฅ์Šค

์š”์•ฝ ๋ถ„์„ Profusa, Inc. Common Stock

์ ‘๊ทผ ๊ถŒํ•œ์„ ์–ป๋‹ค
Finrange ์ฃผ์‹ ๋“ฑ๊ธ‰์—
์ด ์š”๊ธˆ์ œ๋ฅผ ์ด์šฉํ•˜๋ฉด ์ œํ•œ ์—†์ด ์„œ๋น„์Šค๋ฅผ ์ด์šฉํ•  ์ˆ˜ ์žˆ์œผ๋ฉฐ ๋ชจ๋“  ์ •๋ณด๋ฅผ ์ด์šฉํ•  ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.
์–ป๋‹ค 7์ผ ๋ฌด๋ฃŒ

์ฃผ์ฃผ๊ตฌ์กฐ Profusa, Inc. Common Stock

์ˆ˜์ต ๋ฐ ์ˆœ์ด์ต Profusa, Inc. Common Stock

๋ชจ๋“  ๋งค๊ฐœ๋ณ€์ˆ˜

ํšŒ์‚ฌ์†Œ๊ฐœ Profusa, Inc. Common Stock

Profusa, Inc. develops bioengineered sensors for body to detect and continuously transmit clinical-grade data for personal and medical use in the United States. It offers the Lumee Oxygen Platform to monitor compromised tissue for peripheral artery disease, chronic wounds, and reconstructive surgery. The company researches and develops the Lumee Glucose Platform which is designed to monitor glucose levels in interstitial fluid. Profusa, Inc. is based in Berkeley, California.
์ฃผ์†Œ:
626 Bancroft Way, Berkeley, CA, United States, 94710
ํšŒ์‚ฌ ์ด๋ฆ„: Profusa, Inc. Common Stock
๋ฐœํ–‰์ž ํ‹ฐ์ปค: PFSA
๊ตญ๊ฐ€: ๋ฏธ๊ตญ
๊ตํ™˜: NASDAQ
ํ†ตํ™”: $
IPO ๋‚ ์งœ: 2025-07-11
๋Œ€์ง€: https://profusa.com